Aptevo Therapeutics (APVO) Other Non Operating Income (2015 - 2026)
Aptevo Therapeutics (APVO) reported Other Non Operating Income of $87,000 for Q2 2026, up 295.5% from $22,000 a year earlier but down 37.9% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Other Non Operating Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aptevo Therapeutics' Other Non Operating Income came in at $478,000, up 73.2% year-over-year; for FY2025, it was $345,000, down 26.9% from FY2024.
- Other Non Operating Income has declined for three consecutive years.
- By year, Other Non Operating Income came in at $472,000 in FY2024 (-18.3%), $578,000 in FY2023 (-98.4%), $37.18 million in FY2022 and -$8.01 million in FY2021.
- Five-year quarterly Other Non Operating Income spans a low of -$2.56 million in Q4 2021 and a high of $37.18 million in Q2 2022.
- Year over year, Other Non Operating Income has now increased in each of the last three quarters, with growth averaging 33.3% over the last eight quarters.
- The high point for year-over-year Other Non Operating Income in five years was Q2 2026 (growth of 295.5%); the low point was Q2 2023 (a decline of 99.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $140,000 (Q1 2026), $190,000 (Q4 2025) and $61,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Aptevo Therapeutics | 2.50 Mn | -64.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87,000.00 |
| Mar 31, 2026 | 140,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 227,000.00 |
| Jun 30, 2023 | 230,000.00 |
| Mar 31, 2023 | -67,000.00 |
| Sep 30, 2022 | -25,000.00 |
| Jun 30, 2022 | 37.18 Mn |
| Mar 31, 2022 | -2.26 Mn |
| Dec 31, 2021 | -2.56 Mn |
| Sep 30, 2021 | -2.33 Mn |
| Jun 30, 2021 | -2.34 Mn |
API Access
Aptevo Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();